Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Histogen
Biotech
Histogen winds down after search for solutions comes up short
Two months after halting its remaining development program in an attempt to conserve cash, Histogen has run out of options and will wind down.
James Waldron
Sep 19, 2023 8:50am
Histogen halts last remaining programs to conserve cash
Jul 6, 2023 9:00am
Biotechs shed dead wood from pipelines amid cash crunch
Nov 11, 2022 9:25am
Histogen seeks to tear up COVID-19 R&D pact and go solo
Mar 11, 2022 7:20am
After NASH flops, Conatus becomes Histogen via reverse merger
Jan 29, 2020 10:05am
